Literature DB >> 21748281

Fragile X-associated disorders: a clinical overview.

Anne Gallagher1, Brian Hallahan.   

Abstract

Fragile X Syndrome (FraX) is the most common inherited cause of learning disability worldwide. FraX is an X-linked neuro-developmental disorder involving an unstable trinucleotide repeat expansion of cytosine guanine guanine (CGG). Individuals with the full mutation of FraX have >200 GG repeats with premutation carriers having 55-200 GG repeats. A wide spectrum of physical, behavioural, cognitive, psychiatric and medical problems have been associated with both full mutation and premutation carriers of FraX. In this review, we detail the clinical profile and examine the aetiology, epidemiology, neuropathology, neuroimaging findings and possible management strategies for individuals with both the full mutation and premutation of FraX.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21748281     DOI: 10.1007/s00415-011-6161-3

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  160 in total

1.  Chemical induction of mGluR5- and protein synthesis--dependent long-term depression in hippocampal area CA1.

Authors:  K M Huber; J C Roder; M F Bear
Journal:  J Neurophysiol       Date:  2001-07       Impact factor: 2.714

2.  Autism spectrum disorders and attention-deficit/hyperactivity disorder in boys with the fragile X premutation.

Authors:  Faraz Farzin; Hazel Perry; David Hessl; Danuta Loesch; Jonathan Cohen; Susan Bacalman; Louise Gane; Flora Tassone; Paul Hagerman; Randi Hagerman
Journal:  J Dev Behav Pediatr       Date:  2006-04       Impact factor: 2.225

3.  The neurocognitive phenotype of female carriers of fragile X: additional evidence for specificity.

Authors:  M M Mazzocco; B F Pennington; R J Hagerman
Journal:  J Dev Behav Pediatr       Date:  1993-10       Impact factor: 2.225

4.  Nucleus basalis magnocellularis and hippocampus are the major sites of FMR-1 expression in the human fetal brain.

Authors:  M Abitbol; C Menini; A L Delezoide; T Rhyner; M Vekemans; J Mallet
Journal:  Nat Genet       Date:  1993-06       Impact factor: 38.330

5.  Treatment of anxiety using fenobam (a nonbenzodiazepine) in a double-blind standard (diazepam) placebo-controlled study.

Authors:  J C Pecknold; D J McClure; L Appeltauer; L Wrzesinski; T Allan
Journal:  J Clin Psychopharmacol       Date:  1982-04       Impact factor: 3.153

6.  FMRP expression as a potential prognostic indicator in fragile X syndrome.

Authors:  F Tassone; R J Hagerman; D N Iklé; P N Dyer; M Lampe; R Willemsen; B A Oostra; A K Taylor
Journal:  Am J Med Genet       Date:  1999-05-28

7.  Expanded clinical phenotype of women with the FMR1 premutation.

Authors:  Sarah M Coffey; Kylee Cook; Nicole Tartaglia; Flora Tassone; Danh V Nguyen; Ruiqin Pan; Hannah E Bronsky; Jennifer Yuhas; Mariya Borodyanskaya; Jim Grigsby; Melanie Doerflinger; Paul J Hagerman; Randi J Hagerman
Journal:  Am J Med Genet A       Date:  2008-04-15       Impact factor: 2.802

8.  Teasing apart the heterogeneity of autism: Same behavior, different brains in toddlers with fragile X syndrome and autism.

Authors:  Heather Cody Hazlett; Michele D Poe; Amy A Lightbody; Guido Gerig; James R Macfall; Allison K Ross; James Provenzale; Arianna Martin; Allan L Reiss; Joseph Piven
Journal:  J Neurodev Disord       Date:  2009-03       Impact factor: 4.025

9.  An anthropometric study of males with the fragile-X syndrome.

Authors:  D L Meryash; C E Cronk; B Sachs; P S Gerald
Journal:  Am J Med Genet       Date:  1984-01

Review 10.  Phenotypic variation and FMRP levels in fragile X.

Authors:  Danuta Z Loesch; Richard M Huggins; Randi J Hagerman
Journal:  Ment Retard Dev Disabil Res Rev       Date:  2004
View more
  33 in total

1.  Single-locus enrichment without amplification for sequencing and direct detection of epigenetic modifications.

Authors:  Thang T Pham; Jun Yin; John S Eid; Evan Adams; Regina Lam; Stephen W Turner; Erick W Loomis; Jun Yi Wang; Paul J Hagerman; Jeremiah W Hanes
Journal:  Mol Genet Genomics       Date:  2016-01-29       Impact factor: 3.291

2.  Cognitive aspects of Fragile X syndrome.

Authors:  Lillie B Huddleston; Jeannie Visootsak; Stephanie L Sherman
Journal:  Wiley Interdiscip Rev Cogn Sci       Date:  2014-05-29

Review 3.  Recent advances in clinical neurogenetics.

Authors:  José Berciano
Journal:  J Neurol       Date:  2012-11-16       Impact factor: 4.849

4.  Symptoms of Autism in Males with Fragile X Syndrome: A Comparison to Nonsyndromic ASD Using Current ADI-R Scores.

Authors:  Andrea McDuffie; Angela John Thurman; Randi J Hagerman; Leonard Abbeduto
Journal:  J Autism Dev Disord       Date:  2015-07

5.  Improving preimplantation genetic diagnosis for Fragile X syndrome: two new powerful single-round multiplex indirect and direct tests.

Authors:  Emmanuelle Kieffer; Jean-Christophe Nicod; Nathalie Gardes; Claire Kastner; Nicolas Becker; Catherine Celebi; Olivier Pirrello; Catherine Rongières; Isabelle Koscinski; Philippe Gosset; Céline Moutou
Journal:  Eur J Hum Genet       Date:  2015-05-13       Impact factor: 4.246

6.  Dendritic channelopathies contribute to neocortical and sensory hyperexcitability in Fmr1(-/y) mice.

Authors:  Yu Zhang; Audrey Bonnan; Guillaume Bony; Isabelle Ferezou; Susanna Pietropaolo; Melanie Ginger; Nathalie Sans; Jean Rossier; Ben Oostra; Gwen LeMasson; Andreas Frick
Journal:  Nat Neurosci       Date:  2014-11-10       Impact factor: 24.884

7.  Fragile X Syndrome-Associated Emergency Department Visits in the United States, 2006-2011.

Authors:  Thuy Quynh N Do; Catharine Riley; Pangaja Paramsothy; Lijing Ouyang; Julie Bolen; Scott D Grosse
Journal:  Am J Intellect Dev Disabil       Date:  2020-03

8.  BRCA1/2 mutations and FMR1 alleles are randomly distributed: a case control study.

Authors:  Efrat Dagan; Yoram Cohen; Adi Mory; Vardit Adir; Zvi Borochowitz; Hila Raanani; Alina Kurolap; Svetlana Melikhan-Revzin; Dror Meirow; Ruth Gershoni-Baruch
Journal:  Eur J Hum Genet       Date:  2013-11-27       Impact factor: 4.246

9.  Detailed assessment of incontinence in boys with fragile-X-syndrome in a home setting.

Authors:  Justine Niemczyk; Alexander von Gontard; Monika Equit; Katharina Bauer; Teresa Naumann; C Wagner; Leopold Curfs
Journal:  Eur J Pediatr       Date:  2016-08-27       Impact factor: 3.183

Review 10.  The role of genetics in the establishment and maintenance of the epigenome.

Authors:  Covadonga Huidobro; Agustin F Fernandez; Mario F Fraga
Journal:  Cell Mol Life Sci       Date:  2013-03-10       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.